Names | |
---|---|
Preferred IUPAC name
2-Acetamido-5-amino-5-oxopentanoic acid | |
Other names
2-(Acetylamino)-glutaramidic acid | |
Identifiers | |
| |
3D model (JSmol) |
|
ChemSpider |
|
DrugBank |
|
ECHA InfoCard | 100.017.862 |
EC Number |
|
KEGG |
|
MeSH | aceglutamide |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C7H12N2O4 | |
Molar mass | 188.183 g·mol−1 |
Appearance | White crystals |
Melting point | 197 °C (387 °F; 470 K) |
Related compounds | |
Related alkanoic acids |
|
Related compounds |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Aceglutamide (brand name Neuramina), or aceglutamide aluminium (brand name Glumal), also known as acetylglutamine, is a psychostimulant, nootropic, and antiulcer agent that is marketed in Spain and Japan.[1][2][3][4] It is an acetylated form of the amino acid L-glutamine, the precursorofglutamate in the body and brain.[5] Aceglutamide functions as a prodrug to glutamine with improved potency and stability.[5]
Aceglutamide is used as a psychostimulant and nootropic, while aceglutamide aluminium is used in the treatment of ulcers.[6][7][8][9] Aceglutamide can also be used as a liquid-stable source of glutamine to prevent damage from protein energy malnutrition.[10][11][12] The drug has shown neuroprotective effects in an animal modelofcerebral ischemia.[5]
| |
---|---|
H2 antagonists ("-tidine") |
|
Prostaglandins (E)/ analogues ("-prost-") |
|
Proton-pump inhibitors ("-prazole") |
|
Potassium-competitive acid blockers ("-prazan") |
|
Others |
|
Combinations |
|
| |
|
| |
---|---|
Magnesium (increases motility) |
|
Aluminium (decreases motility) |
|
Calcium |
|
Sodium |
|
Combinations and complexes of aluminium, calcium and magnesium |
|